Reports by Industry
Reports by Company
- Company Analysis(173)
- Company Profile(60)
Global & US Gene Therapy Market Forecast to 2020
Format : 
Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : May, 2019| No. of Pages : 205
Please make your selection :
Electronic Access - Single User License
US$ 2200.00
CD-ROM Mail Delivery
US$ 2400.00
Hard Copy Mail Delivery
US$ 2400.00
Electronic Access - Multi-User License
US$ 2800.00
1. Analyst View
2. Research Methodology
3. Gene Therapy - An Introduction
3.1 Classification of Gene Therapy Techniques
3.2 Physical Methods of Gene Transfer
3.2.1 Electroporation
3.2.2 Hydrodynamic
3.2.3 Microinjection
3.2.4 Particle Bombardment
3.2.5 Ultrasound-Mediated Transfection
3.3 Vectors for Gene Therapy
3.3.1 Viral Vectors
3.3.1.1 Adenoviral Vectors
3.3.1.2 Adeno-associated Virus Vectors
3.3.1.3 Retroviral Vectors
3.3.1.4 Lentiviral Vectors
3.3.2 Non Viral Vectors
3.3.2.1 Naked DNA/Plasmid Vectors
3.3.2.2 Oligonucleotides
3.3.2.3 Liposomes, Lipoplexes and Polyplexes
3.3.2.4 Gene-Activated Matrix
4. Industry Overview
4.1 Market Drivers
4.1.1 Failure of Conventional Therapies to Treat Cancers
4.1.2 Rising Focus to Accelerate Commercialization of Gene Therapy in Developed Nations
4.1.3 Rising Incidence of Chronic and Life-Threatening Diseases
4.1.4 Growing Interest of Venture Capital Firms
4.2 Market Restraints
4.2.1 Stringent Regulatory Laws & Safety Concerns
4.2.2 Challenges in Commercialization of Gene Therapy
4.2.3 High Cost of the Gene Therapy Drugs
4.2.4 Pitfalls in Current Technique
4.2.5 Production & Manufacturing: A Unique Challenge for Gene Therapies
4.3 Market Opportunities
4.3.1 Approval of Gene Therapy Drug in Europe
4.3.2 Gene Therapy for Hemophilia B Offers Significant Opportunity
4.4 Industry Trends
4.4.1 Gene Silencing: Gaining Momentum
4.4.2 Advanced Therapies: Combining Gene Therapy and Stem Cell Technology
4.4.3 Immunodeficiency Syndromes: The Focus of Gene Therapy
4.4.4 Nanotechnology: Empowering Gene Therapy
4.4.5 Gene Therapy: A New Hope to Treat Blindness
4.4.6 Gene Therapy: Potential Cure for Cancer
4.5 Winning Imperatives
4.5.1 Investment in R&D Activities
5. Clinical Trial Assessment & Pipeline Analysis
5.1 Clinical Trials
5.1.1 By Geography
5.1.2 By Indication
5.1.3 By Gene Type
5.1.4 By Vector
5.1.5 By Clinical Trial Phase
5.2 Pipeline Analysis
6. Gene Therapy Market - Regulatory Landscape & Reimbursement Scenario
6.1 Regulatory Landscape
6.1.1 US
6.1.2 Canada
6.1.3 Europe
6.1.4 Japan
6.1.5 China
6.1.6 India
6.1.7 Australia
6.2 Reimbursement Scenario in Global Market
7. Marketed Gene Therapies
7.1 Neovasculgen
7.2 Glybera
7.3 Gendicine, Rexin-G, Oncorine
7.3.1 Gendicine
7.3.2 Rexin G
7.3.3 Oncorine
8. Gene Therapy Market
8.1 Global
8.2 US
9. Gene Therapy Market by Application
9.1 Oncology
9.1.1 Clinical Trials
9.1.2 Prevalence
9.1.3 Market Outlook
9.2 Cardiovascular Diseases
9.2.1 Clinical Trials
9.2.2 Prevalence
9.2.3 Market Outlook
9.3 Infectious Diseases
9.3.1 Clinical Trials
9.3.2 Prevalence
9.3.3 Market Outlook
9.4 Neurological Diseases
9.4.1 Clinical Trials
9.4.2 Prevalence
9.4.3 Market Outlook
9.5 Genetic Diseases
9.5.1 Clinical Trials
9.5.2 Prevalence
9.5.3 Market Outlook
9.6 Others
9.6.1 Clinical Trials
9.6.2 Prevalence
9.6.3 Market Outlook
10. Gene Therapy Market Size by Geography
10.1 North America
10.2 Europe
10.3 Asia
10.4 Rest of the World (RoW)
11. Competitive Landscape
11.1 Strategies Adopted by Various Players
11.1.1 Strategic Collaborations
11.1.2 Acquisitions
11.1.3 Funding & Investments
11.2 Companies Progress in Gene Therapy In 2015
12. Key Players Analysis (Business Description, Clinical Pipeline, Recent Developments, Strengths & Weaknesses)
12.1 Spark Therapeutics, LLC
12.2 ViroMed Co. Ltd. dba VM BioPharma
12.3 Advantagene Inc.
12.4 Bluebird Bio
12.5 Sanofi
12.6 Vical Inc.
12.7 Oxford BioMedica Plc
12.8 Genethon
12.9 uniQure N.V.
12.10 Human Stem Cells Institute
12.11 Shanghai Sunway Biotech Co. Ltd.
12.12 Sibiono GeneTech Co. Ltd.
Not able to find data you are looking for? Ask our Research Analyst.
media citation
- testtest
19 Jan, 2024 - Yourstory.com News @ Foodtech startup Swiggy launches Health Hub in Chennai
23 Mar, 2021 - Yourstory.com News @ Zomato forays into dietary supplements, makes its own 'made in India' brand
16 Mar, 2021 - View more
get in touch
Copyright © 2018, RNCOS, 2002-2018
About Us
Terms & Policy
Contact